Prevalencia de Chlamydia trachomatis en conjuntivitis neonatal determinada mediante las técnicas de inmuno- fluorescencia y amplificación génica
Backgrund: Chlamydia trachomatis is one of the most common identifiable infectious agents in neonatal conjunctivitis. It also causes pneumonitis, that is preceded by conjunctivitis in one third of cases. Aim: To asses the prevalence of Chlamydia trachomatis in newborns with conjunctivitis. Patients...
Guardado en:
Autores principales: | , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2000
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000700008 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872000000700008 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720000007000082000-09-01Prevalencia de Chlamydia trachomatis en conjuntivitis neonatal determinada mediante las técnicas de inmuno- fluorescencia y amplificación génicaValencia O,CarolinaPrado J,ValeriaRíos,MaritzaCruz,María AntonietaJacques Pilorget,Jean Antibiotics Chlamydia infections Chlamydia trachomatis Backgrund: Chlamydia trachomatis is one of the most common identifiable infectious agents in neonatal conjunctivitis. It also causes pneumonitis, that is preceded by conjunctivitis in one third of cases. Aim: To asses the prevalence of Chlamydia trachomatis in newborns with conjunctivitis. Patients and methods: In 162 newborns, coming from 14 Primary Health Centers from Santiago de Chile, C. trachomatis was detected by indirect fluorescence and two polymerase chain reaction (PCR 1 and 2), wich amplified different sequences from the common endogenous plasmid. Those patients with positive indirect fluorescence and PCR 2 were definedas infected: Results: The prevalence of C. trachomatis was 8%, and the distribution of the positive cases was similar in the different Health Centers. Other isolates were: S. aureus (9.8%), S. pneumoniae (8%), S. viridans (6.2%) y H. influenzae (5.5%). Conclusions: The prevalence of C. trachomatis in neonatal conjunctivitis in Chile is similar to that of developed countries. Therefore, C. trachomatis should be considered in the election of antimicrobials for the treatment of neonatal conjunctivitis, to avoid ocular and respiratory complications. (Rev Méd Chile 2000; 128: 758-65).info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.128 n.7 20002000-07-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000700008es10.4067/S0034-98872000000700008 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Antibiotics Chlamydia infections Chlamydia trachomatis |
spellingShingle |
Antibiotics Chlamydia infections Chlamydia trachomatis Valencia O,Carolina Prado J,Valeria Ríos,Maritza Cruz,María Antonieta Jacques Pilorget,Jean Prevalencia de Chlamydia trachomatis en conjuntivitis neonatal determinada mediante las técnicas de inmuno- fluorescencia y amplificación génica |
description |
Backgrund: Chlamydia trachomatis is one of the most common identifiable infectious agents in neonatal conjunctivitis. It also causes pneumonitis, that is preceded by conjunctivitis in one third of cases. Aim: To asses the prevalence of Chlamydia trachomatis in newborns with conjunctivitis. Patients and methods: In 162 newborns, coming from 14 Primary Health Centers from Santiago de Chile, C. trachomatis was detected by indirect fluorescence and two polymerase chain reaction (PCR 1 and 2), wich amplified different sequences from the common endogenous plasmid. Those patients with positive indirect fluorescence and PCR 2 were definedas infected: Results: The prevalence of C. trachomatis was 8%, and the distribution of the positive cases was similar in the different Health Centers. Other isolates were: S. aureus (9.8%), S. pneumoniae (8%), S. viridans (6.2%) y H. influenzae (5.5%). Conclusions: The prevalence of C. trachomatis in neonatal conjunctivitis in Chile is similar to that of developed countries. Therefore, C. trachomatis should be considered in the election of antimicrobials for the treatment of neonatal conjunctivitis, to avoid ocular and respiratory complications. (Rev Méd Chile 2000; 128: 758-65). |
author |
Valencia O,Carolina Prado J,Valeria Ríos,Maritza Cruz,María Antonieta Jacques Pilorget,Jean |
author_facet |
Valencia O,Carolina Prado J,Valeria Ríos,Maritza Cruz,María Antonieta Jacques Pilorget,Jean |
author_sort |
Valencia O,Carolina |
title |
Prevalencia de Chlamydia trachomatis en conjuntivitis neonatal determinada mediante las técnicas de inmuno- fluorescencia y amplificación génica |
title_short |
Prevalencia de Chlamydia trachomatis en conjuntivitis neonatal determinada mediante las técnicas de inmuno- fluorescencia y amplificación génica |
title_full |
Prevalencia de Chlamydia trachomatis en conjuntivitis neonatal determinada mediante las técnicas de inmuno- fluorescencia y amplificación génica |
title_fullStr |
Prevalencia de Chlamydia trachomatis en conjuntivitis neonatal determinada mediante las técnicas de inmuno- fluorescencia y amplificación génica |
title_full_unstemmed |
Prevalencia de Chlamydia trachomatis en conjuntivitis neonatal determinada mediante las técnicas de inmuno- fluorescencia y amplificación génica |
title_sort |
prevalencia de chlamydia trachomatis en conjuntivitis neonatal determinada mediante las técnicas de inmuno- fluorescencia y amplificación génica |
publisher |
Sociedad Médica de Santiago |
publishDate |
2000 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000000700008 |
work_keys_str_mv |
AT valenciaocarolina prevalenciadechlamydiatrachomatisenconjuntivitisneonataldeterminadamediantelastecnicasdeinmunofluorescenciayamplificaciongenica AT pradojvaleria prevalenciadechlamydiatrachomatisenconjuntivitisneonataldeterminadamediantelastecnicasdeinmunofluorescenciayamplificaciongenica AT riosmaritza prevalenciadechlamydiatrachomatisenconjuntivitisneonataldeterminadamediantelastecnicasdeinmunofluorescenciayamplificaciongenica AT cruzmariaantonieta prevalenciadechlamydiatrachomatisenconjuntivitisneonataldeterminadamediantelastecnicasdeinmunofluorescenciayamplificaciongenica AT jacquespilorgetjean prevalenciadechlamydiatrachomatisenconjuntivitisneonataldeterminadamediantelastecnicasdeinmunofluorescenciayamplificaciongenica |
_version_ |
1718435927523590144 |